An Open-Label Study to Evaluate the Single-Dose Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients ≥ 3 Months to <18 Years of Age, Undergoing Treatment With Systemic Antibiotics
Phase of Trial: Phase I
Latest Information Update: 28 Aug 2015
At a glance
- Drugs Ceftobiprole medocaril (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Sponsors Basilea Pharmaceutica; Johnson & Johnson
- 26 Jul 2012 Additional company (Basilea Pharmaceutica) added in association as reported by ClinicalTrials.gov.
- 21 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.